USPSTF Prevention TaskForce vs Lipid Manager

The Prevention TaskForce (formerly ePSS) is an application designed and developed by the U.S. Department of Health & Human Services (HHS), Agency for Healthcare Research and Quality (AHRQ), the Nation's lead Federal agency for research on health care quality, costs, outcomes and patient safety. It was developed by AHRQ to support the independent U.S. Preventive Services Task Force (USPSTF). The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine. AHRQ provides support to the USPSTF. The Prevention TaskForce application was developed to assist primary care clinicians identify the screening, counseling, and preventive medication services that are appropriate for their patients. The Prevention TaskForce information is based on the current recommendations of the U.S. Preventive Services Task Force (USPSTF) and can be searched by specific patient characteristics, such as age, sex, and selected behavioral risk factors. When using this tool please read the specific recommendation to determine if the preventive service is appropriate for your patient. This tool is not meant to replace clinical judgment and individualized patient care. *Application downloads and data updates require internet connectivity

The ACC Lipid Manager app provides two clinical decision support tools in one app to help clinicians manage a patient’s triglycerides and LDL-C from therapy initiation through treatment calibration with the goal of lowering ASCVD risk: •  Lipid Lowering Therapy tool: Supports selection of lipid‑lowering therapies and individualized goals to reduce ASCVD risk through targeted management of LDL-C and triglycerides (previously known as LDL-C Lowering Therapy) •  Statin Intolerance tool: Evaluate the patient for possible statin intolerance, and determine appropriate next steps The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgement. Therapeutic options should be determined after discussion between the patient and their care provider. Financial support for Lipid Manager was provided by Esperion. All content was independently developed with no sponsor involvement.